Literature DB >> 6889460

Epileptic seizures associated with cisplatin administration.

G M Mead, A M Arnold, J A Green, F R Macbeth, C J Williams, J M Whitehouse.   

Abstract

Eighty-one patients with germ cell tumors or ovarian carcinoma were treated over a 4-year period with cisplatin-containing combination chemotherapy. Eight patients (9.8%) experienced epileptic seizures during or within 3 months of this chemotherapy. While a definite causal relationship between the seizures and cisplatin could not be established, we have rarely seen such episodes in relationship to other cytotoxic drugs. A number of possible contributing factors were apparent, including hyponatremia and pretreatment impairment of renal function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889460

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  10 in total

1.  Convulsions and transient cortical blindness after cisplatin.

Authors:  P A Philip; J Carmichael; A L Harris
Journal:  BMJ       Date:  1991-02-16

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Cisplatin-induced gastric paresis.

Authors:  S C Cohen; J E Mollman
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 4.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

5.  Seizures after antiemetic treatment with high dose domperidone: report of four cases.

Authors:  A Weaving; W R Bezwoda; D P Derman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-09

6.  Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil.

Authors:  G M Mead; C J Williams; J M Whitehouse
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.

Authors:  A Olivi; M Gilbert; K L Duncan; B Corden; D Lenartz; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 8.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Cerebral herniation in patients receiving cisplatin.

Authors:  R W Walker; J G Cairncross; J B Posner
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

10.  Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report.

Authors:  Laura L Holman; Yulan Ren; Shannon N Westin
Journal:  BMC Cancer       Date:  2015-10-17       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.